Shark Tank Judge Invests In All-Natural Alcohol Detox Beverage [Forbes]
Quantum Biopharma Ltd. - Class B Subordinate Voting Shares (QNTM)
Company Research
Source: Forbes
his latest venture— an early investment in the emerging alcohol detox drink, unbuzzd. Harrington, who has launched over 1,000 products across more than 100 countries, generating over $6 billion in global sales, sees unbuzzd as a potential game-changer in the functional beverage market. "It's a revolution in how we recover from alcohol," Harrington claims. Kevin Harrington, says unbuzzd is "a revolution in how we recover from alcohol." Quantum Biopharma Harrington describes unbuzzd as more than just a hangover remedy, describing the detox drink as a "disruptive innovation built on science," aimed at transforming how people think about alcohol recovery. Unlike traditional hangover cures that simply alleviate symptoms, unbuzzd takes a proactive approach by helping the body process alcohol more efficiently. The goal is to restore mental clarity, boost cognitive function, and allow consumers to enjoy alcohol responsibly while still waking up feeling refreshed the next day. The re
Show less
Read more
Impact Snapshot
Event Time:
QNTM
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
QNTM alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
QNTM alerts
High impacting Quantum Biopharma Ltd. - Class B Subordinate Voting Shares news events
Weekly update
A roundup of the hottest topics
QNTM
News
- Quantum Biopharma Announces that Sentinel Dosing has Started for the Phase-1 Multiple Ascending Dose Clinical Trial for Lucid-21-302 (Lucid-Ms) in AustraliaAccesswire
- Christian Attar Files Market Manipulation Case On Behalf of Quantum BiopharmaPR Newswire
- Freedman Normand Friedland Files Market Manipulation Case On Behalf of Quantum BiopharmaPR Newswire
- Quantum Biopharma (NASDAQ:QNTM) Posts Link on Its Website to Access the Filed Complaint Against CIBC World Markets, RBC Dominion Securities and Others, Seeking Damages in Excess of $700,000,000 USD, for Possible Stock Price Manipulation/SpoofingAccesswire
- Quantum BioPharma (Nasdaq: QNTM) Files a US Federal Lawsuit Against CIBC World Markets, RBC Dominion Securities and Others, Seeking Damages in Excess of $700,000,000 USD, for Possible Stock Price Manipulation/SpoofingAccesswire
QNTM
Sec Filings
- 11/12/24 - Form 6-K
- 10/29/24 - Form 6-K
- 10/22/24 - Form 6-K
- QNTM's page on the SEC website